QuesGen Platform vs. AQ Platform

We offer a diverse array of solutions that range from simple turnkey systems to comprehensive multi-site research initiatives, aiding principal investigators in overcoming common issues related to database selection and configuration. Researchers often seek out QuesGen for specialized advice on the best practices for data management and additional services that help expedite the commencement of their research studies. As a trusted partner for a variety of academic institutions and researchers, we are adept at managing large datasets and performing data curation through our versatile data platform, which supports the quick and efficient launch and scaling of research projects. Our extensive data model, along with a repository of assessments and curation expertise, reflects QuesGen's commitment to getting you operational in no time while ensuring the delivery of high-quality, compliant data that allows you to focus on analyzing your results. Our offerings cater to a wide range of clinical research activities within your organization, conforming to HIPAA regulations and FDA 21 CFR Part 11 standards, and they can be effortlessly integrated with your electronic medical records systems as well as the Federal Interagency TBI Repository (FITBIR). By utilizing our services, researchers can not only improve their efficiency but also enhance their workflows, ultimately contributing to more significant and impactful research results, while fostering a collaborative environment that encourages innovation and discovery.

The AQ Platform is a sophisticated software solution designed specifically for overseeing clinical research across various entities such as NHS trusts, clinical trial units, investigator sites, site networks, CROs, sponsors, and academic research organizations. It includes an array of modules that support trial management, electronic documentation for both trials and investigator sites, operations in pharmacies and laboratories, quality assurance, corrective and preventive actions (CAPA), along with the digital delegation of authority. This platform facilitates the seamless integration of regulated trial records and comprehensive audit trails, leading to improved efficiency in study operations. By harnessing Connected Intelligence, the software utilizes AI to pinpoint potential gaps and propose subsequent actions, with the stipulation that each recommendation must be validated by a designated user, thereby ensuring that customer data remains confidential and is not employed for AI model training. Hosted within the UK regions of Microsoft Azure, the AQ Platform is meticulously crafted to comply with ICH E6(R3) guidelines and meets the standards anticipated by the MHRA for Good Clinical Practice inspections. Furthermore, AQ Trials has received the NHS DSPT Standards Met (2026) designation and holds Cyber Essentials certification, underscoring its dedication to security and adherence to regulatory requirements. Created by physicians specializing in Phase 1 trials, the system offers the flexibility of individual module deployment, and it has been actively implemented in NHS operations since 2020, which highlights its effectiveness and reliability in practical clinical environments. The platform is continuously being enhanced based on user feedback, ensuring it adapts to the evolving demands of clinical research while maintaining high standards of performance and user satisfaction. As a result, it stands as a robust solution in the ever-changing landscape of clinical trial management.